The Business Ethics for APEC SMEs Initiative in the Biopharmaceutical sector works to identify, align, and endorse the highest standard ethical business practices across all member economies.
This initiative has convened experts to develop the Mexico City Principles, finalize Vision 2025, and many other key guiding documents (below). Please click the following links for more information.
Key Documents
- Mexico City Principles for Voluntary Codes of Business Ethics in the Biopharmaceutical Sector English | Chinese 官话 | Spanish Español | Japanese 日本の | Thai ไทย | Indonesian | Vietnamese
- Vision 2025
- The Benefits of Embracing Ethical Business Conduct: A Literature Review for the Business Ethics for the APEC SMEs Initiative
- IFPMA Note for Guidance on Patient and Patient Organization Interactions
- Draft Patient Action Plan for Vision 2025
- Statement by Patients and Patient Organizations on Reinforcing Ethics and Business Integrity in Healthcare
- Draft Healthcare Professional Action Plan for Vision 2025
- Guidance for Ethical Third-Party Intermediary Relationships in the Biopharmaceutical Sector
- Government Strategies to Encourage Ethical Business Conduct: A Resource Guide for Economies from the Business Ethics for APEC Initiative
- Business Ethics for APEC SMEs Initiative Strategic Assessment of 2020 Commitments
- The Mexico City Principles for Voluntary Codes of Business Ethics in the Biopharmaceutical Sector
- The Nanjing Declaration to Promote Ethical Business Practices in the Medical Device and Biopharmaceutical Sectors (2014-2020)
- APEC Guidance for Ethical Third Party Intermediary Relationships in the Medical Device Sector
- Tokyo Action Agenda Recommendations
- Guide to Facilitate Multi-Stakeholder Ethical Collaborations in the Medical Device and Biopharmaceutical Sectors (English)
- 2024 Call to Action: Report
Initiative Reports
- 2022 Report on Code of Ethics Implementation by APEC Biopharmaceutical Industry Associations
- 2021 Report on Code of Ethics Implementation by APEC Biopharmaceutical Industry Associations
- 2020 Report on Code of Ethics Implementation by APEC Biopharmaceutical Industry Associations
- 2019 Report on Code of Ethics Implementation by APEC Biopharmaceutical Industry Associations
- 2018 Report on Code of Ethics Implementation by APEC Biopharmaceutical Industry Associations
- 2017 Report on Code of Ethics Implementation by APEC Biopharmaceutical Industry Associations
- 2016 Report on Code of Ethics Implementation by APEC Biopharmaceutical Industry Associations
Introductory Modules
- Communicating the Value of High-Standard Business Ethics (Internally) – Challenges and Opportunities
- Communicating the Value of High-Standard Business Ethics (Externally) – Challenges and Opportunities
- Overview – The APEC Mexico City Principles for Voluntary Codes of Ethics in the Biopharmaceutical Sector
- Overview – The Nanjing Declaration and APEC Guide to Promote Multi-Stakeholder Ethical Collaborations
- Overview – The Asia-Pacific Economic Cooperation (APEC) Forum & Business Ethics for APEC SMEs Initiative
Issue Modules
- Embodying the APEC Principles to Address Everyday Questions & Fostering a Ethical Culture
- Biopharmaceutical Industry Interactions with Healthcare Professionals
- Biopharmaceutical Industry Promotional Information and Activities
- Symposia & Congresses
- Conduct and Training of Biopharmaceutical Industry Representatives
- Biopharmaceutical Industry Relationships with the Public Sector and Procurement
- Educational Items and Gifts
- Biopharmaceutical Industry Donations for Charitable Purposes
- Patient Organizations
- Ethical Interactions with Third Party Intermediaries
- Emerging & Other Ethical Considerations in the Biopharmaceutical Sector
2017 APEC Business Ethics for SMEs Forum – Biopharmaceutical Sector Workshop (7 September 2017)
Breakout Course A – Module One (Internal Considerations):
- Case Study One (English)
- Case Study One (Vietnamese)
- Case Study One Facilitator Notes
- Case Study Two (English)
- Case Study Two (Vietnamese)
- Case Study Two Facilitator Notes
- Case Study Three (English)
- Case Study Three (Vietnamese)
- Case Study Three Facilitator Notes
Breakout Course A – Module Two (External Considerations):
Breakout Course B:
- Module One Handout – Status Assessment (English)
- Module Three Handout – Evolving Code Implementation (English)
Interactive, Multi-Stakeholder Exercises:
- Case One User Version (English)
- Case One User Version (Vietnamese)
- Case One Facilitator Version (English)
- Case One Facilitator Version (Vietnamese)
- Case Two User Version (English)
- Case Two User Version (Vietnamese)
- Case Two Facilitator Version (English)
- Case Two Facilitator Version (Vietnamese)
2016 APEC Business Ethics for SMEs Forum – Biopharmaceutical Sector Workshop (5 September 2016)
Case Exercises:
- Exercise One: Industry Interactions with Healthcare Professionals (English & Spanish)
- Exercise Three: Role of Governments in Facilitating Voluntary Ethical Practices (Presentation – English)
- Exercise Three: Role of Governments in Facilitating Voluntary Ethical Practices (Presentation – Spanish)
- Exercise Three: Role of Governments in Facilitating Voluntary Ethical Practices (Handout – English & Spanish)
2015 APEC Business Ethics for SMEs Forum – Biopharmaceutical Sector Workshop (19 August 2015)
Advance Modules:
- The Value and Responsibility of High-Standard Ethics
- Understanding the APEC Mexico City Principles
- The Importance of Promoting Codes of Ethics to Stakeholders
- Setting the Scene: The Role of Compliance
Breakout Team Assignments:
Code Implementation Workshop: